The Exchange has sought clarification from Valiant Laboratories Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The National Stock Exchange (NSE) has formally asked Valiant Laboratories Limited to provide clarification regarding its quarterly financial results for the period ending 31 March 2026. The query is made under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs the submission and disclosure of quarterly financial results by listed companies. As of the filing date, the company has not yet submitted its response to the exchange. The specific reasons or issues prompting the exchange's query are not detailed in this announcement.
Until the company provides a satisfactory clarification, there may be uncertainty around the stock's quarterly performance. Shareholders should monitor for the company's response and any follow-up announcements.